Male contraceptive options remain limited to barrier methods and vasectomy. Research efforts focus on hormonal suppression of spermatogenesis through inhibition of gonadotropin secretion.
Clinical trials combining testosterone and progestins show promising results, though long-term safety and reversibility remain under investigation.
Non-hormonal targets, including sperm motility and maturation pathways, are also being explored.
Expanded contraceptive options could promote shared erotic reproductive responsibility.
Leave a Reply